Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details)

v3.21.2
Note 9 - Earnings Per Share - Shares Used in the Earnings Per Share Computations (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Net earnings, including noncontrolling interest $ 68,981 $ 33,395
Net earnings (loss) attributable to noncontrolling interest (634) 0
Net earnings attributable to Bio-Techne 69,615 33,395
Income allocated to participating securities (36) (21)
Income available to common shareholders $ 69,579 $ 33,374
Basic (in shares) 39,094 38,536
Basic (in dollars per share) $ 1.78 $ 0.87
Net earnings attributable to Bio-Techne $ 69,615 $ 33,395
Income allocated to participating securities (36) (21)
Income available to common shareholders $ 69,579 $ 33,374
Dilutive effect of stock options and restricted stock units (in shares) 2,064 1,489
Diluted (in shares) 41,158 40,025
Diluted (in dollars per share) $ 1.69 $ 0.83